Mebendazole Clinical Trial: Can A Medicine To Treat Infection, Treat Brain Cancer?
We are funding a clinical trial at Johns Hopkins to test whether mebendazole, a drug already approved by the FDA to fight infections, might be an effective anti-brain cancer medication. This drug has a sgtrong safety profile and is available as a generic, which could be widely available in the near term and at a low cost to patients.
Accelerate Brain Cancer Cure is a Washington DC-based venture philanthropy 501(c)(3) nonprofit organization that drives cutting-edge research and treatments for brain tumors. Copyright 2014 ABC2 - All Rights Reserved.